Clinical ManagerBusch Center
Disclosure information not submitted.
Functional, imaging, and oncological outcomes in 42 patients treated with lesion-targeted MRI-guided Transurethral Ultrasound Ablation (TULSA) for prostate cancer lesions at the extreme apex
Monday, March 25, 20244:12 PM – 4:21 PM MT